Johns Hopkins ABX Guide
Ribavirin
INDICATIONS
FDA
FDA
- Hepatitis C in combination with direct-acting antivirals (e.g. sofosbuvir, simeprevir, daclatasvir, etc.) or interferon alpha or peginterferon alpha
- Respiratory syncytial virus (RSV) infection (including bronchiolitis and pneumonia) [inhalation formulation only]
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of progressive vaccinia in combination with vaccinia immune globulin (VIG)[12].
- Treatment of hemorrhagic fever.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 5, 2023
Citation
Smith, Janessa M. "Ribavirin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540479/all/Ribavirin.
Smith JM. Ribavirin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540479/all/Ribavirin. Accessed November 21, 2024.
Smith, J. M. (2023). Ribavirin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540479/all/Ribavirin
Smith JM. Ribavirin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2023. [cited 2024 November 21]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540479/all/Ribavirin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ribavirin
ID - 540479
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2023/03/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540479/all/Ribavirin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
